007 AI & Real World Data - Advancing Cancer Research and Care through the ONCOVALUE initiative
BC Platforms Podcast
Dr. Carolin Bender, Chief Medical Officer for BC Platforms speaks with On Air Media Group about the groundbreaking ONCOVALUE project in collaboration with Helsinki University Hospital (HUS) and other European institutions, that seeks to explore and leverage real-world data (RWD) in the context of cancer research and treatment, and it's dedication to developing an AI-based framework that assesses the real-time, real-life effectiveness of novel cancer therapies.
info_outline
006 Using Genomics to Accelerate Drug Development
BC Platforms Podcast
Today's episode will focus on the topic of using genomics to accelerate drug development. Our host is Tõnu Esko, BC Platforms SAB Chairman and Vice Director of the Institute of Genomics University of Tartu, where he also holds a Professor of Human Genomics position. He is head of the Estonian Biobank Innovation Center and focuses on public private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad Institute of Harvard at MIT. He acts as one of the senior leaders for Estonian personalized medicine programs and serves as a scientific advisor for...
info_outline
005 Accelerated Insights From Data for Preventative Health Innovation
BC Platforms Podcast
Today's podcast will focus on the topic of accelerated insights from data for preventative health innovation. The podcast sheds light on industry challenges and expectations as well as innovative approaches to collaboration. This discussion is led by Tõnu Esko, BC Platforms SAB Chairman and Vice Director of the Institute of Genomics University of Tartu, where he also holds a Professor of Human Genomics position. He is head of the Estonian Biobank Innovation Center and focuses on public private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad...
info_outline
004 Journey Towards Safe and Secure Global Data Access
BC Platforms Podcast
Today's podcast will focus on the topic of the journey to a safe and secure global data access. This podcast sheds light on industry challenges and expectations, as well as innovative approaches to collaboration. The discussion is led by Tõnu Esko, BC Platforms Scientific Advisory Board Chairman, and Vice Director of the Institute of Genomics at the University of Tartu, where he also holds a Professor of Human Genomics position. He is the Head of Estonian Biobank Innovation Center, and focuses on public-private partnerships and innovation transfer. Dr. Esko is also a research scientist at the...
info_outline
003 Real World Data Access for Label Expansion and Drug Discovery
BC Platforms Podcast
Today's episode will focus on the topic of real world data access for label expansion. We are holding an open discussion with a few key leaders on how real world data can be applied in drug development to enhance research and accelerate discoveries. This podcast sheds light on industry challenges and expectations, as well as innovative approaches to collaboration. The discussion is led by Tõnu Esko, BC Platforms Scientific Advisory Board Chairman, and Vice Director of the Institute of Genomics at the University of Tartu, where he also holds a Professor of Human Genomics position. He is...
info_outline
002 Europe Biobank Week: Sharing experiences in partnership: a conversation on collaboration in a global network
BC Platforms Podcast
Welcome to the BC Platforms Podcast! BC Platforms is the global leader in providing a powerful data discovery and analytics platform, as well as data science solutions for personalized health care. BC Platforms enables cross-functional collaboration with our global federated network of data partners. This episode is an open discussion with three key leaders in the healthcare data industry. Tõnu Esko is the Professor of Human Genomics at the University of Tartu, and the longtime leader and member of the Senior Management Board for the Estonian Biobank. Sirpa Soini is...
info_outline
001 Shaping a Data Access Framework for Population Health
BC Platforms Podcast
Welcome to the first episode of the BC Platforms podcast! BC Platforms is the global leader in providing a powerful data discovery and analytics platform, as well as data science solutions for personalized health care. BC Platforms enables cross-functional collaboration with our global federated network of data partners. In today’s episode we are discussing shaping a data access framework for population health. We will shed light on industry challenges and expectations, as well as innovative approaches to collaboration. This episode is hosted by Tõnu Esko, BC Patforms SAB Chairman and Vice...
info_outlineToday's episode will focus on the topic of using genomics to accelerate drug development.
Our host is Tõnu Esko, BC Platforms SAB Chairman and Vice Director of the Institute of Genomics University of Tartu, where he also holds a Professor of Human Genomics position. He is head of the Estonian Biobank Innovation Center and focuses on public private partnerships and innovation transfer. Dr. Esko is also a research scientist at the Broad Institute of Harvard at MIT. He acts as one of the senior leaders for Estonian personalized medicine programs and serves as a scientific advisor for several companies.
Our guest today is Iris Grossman, on the leading edge of Personalized Medicine, Big Data Analytics and Biotech R&D for 20 years. She is Acting CSO of Amide and advises other biotech in her field of expertise. She has held leadership positions and or consulted for top big pharma GSK, Eli Lilly, Takeda and Teva, where she was VP Head of early stage development, startup and consultancies. She specializes in leveraging high dimensional genomic insights and E-health as engines of therapeutic discovery, development and Lifecycle Management across a wide range of modalities and therapeutic areas. Iris also serves as SAB member of BC platforms, Tipa Biobank, Eleven Therapeutics and CGRP Diagnostics. She earned her B.Sc. in Medicine at the Technion, and a PhD in Medicine, Population Genomics and Pharmacogenomics for the Technion, co-mentored with the Weitzman Institute. Next, she was a postdoc fellow in Personalized Medicine and Population Genomics at Duke University.
What is covered:
- The benefits of using big data in drug discovery
- Specific examples of how the genetics could be helpful in the drug discovery, such as the contribution of human genetics and genomics to fighting COVID
- The recommendations to stakeholders for collaborating within the industry for the sake of innovation
- How biobanks can potentially act as middlemen for this new type of collaboration
Resources:
- The Institute of Genomics, University of Tartu https://genomics.ut.ee/en
- The Estonian Biobank https://genomics.ut.ee/en
- Amide Technologies https://www.amidetech.com/
- GSK https://www.gsk.com/
- Eli Lilly https://www.lilly.com/
- Takeda https://www.takeda.com/
- Teva Pharmaceutical https://www.tevapharm.com/
- Tipa Biobank https://www.ksminnovation.com/biobank
- Eleven Therapeutics https://eleventx.com/
- CGRP Diagnostics http://cgrpdiagnostics.com/
Connect with Iris Grossman:
- https://www.linkedin.com/in/irisgrossman/
Connect with Dr. Tõnu Esko:
- https://www.linkedin.com/in/tõnu-esko-24511524/
Connect with BC Platforms: